<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoXBRL; Version: 4.26b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: O:\PRODUCTION_XBRL\Live Jobs\Alberton Acquisition Corp\20190331_Q1\May 13, 2019\Xfr\alac_20190331.xfr; Date: 2019%2D05%2D13T14:24:56Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2018-01-31" xmlns:us-roles="http://fasb.org/us-roles/2018-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:srt="http://fasb.org/srt/2018-01-31" xmlns:ALAC="http://ALAC/20190331">
    <link:schemaRef xlink:href="alac-20190331.xsd" xlink:type="simple" />
    <xbrli:context id="From2018-02-16to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-02-16</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-02-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-02-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-02to2018-07-06_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-02</xbrli:startDate>
        <xbrli:endDate>2018-07-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-07-06_custom_SponsorMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-07-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_TrustAccountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ALAC:TrustAccountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2018-10-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-26_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2018-10-26_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2018-10-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2018-10-26_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2018-10-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2018-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember_custom_TrustAccountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ALAC:TrustAccountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2018-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-20_us-gaap_OverAllotmentOptionMember_custom_TrustAccountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ALAC:TrustAccountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-02-16to2018-12-31_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-02-16</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-26_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-01to2018-11-20_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2018-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-20_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-01to2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ALAC:SaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2018-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ALAC:SaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ALAC:SaleOfStockAxis">ALAC:PurchaseOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2018-10-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ALAC:SaleOfStockAxis">ALAC:PurchaseOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-01to2018-11-20_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ALAC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2018-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-05_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-05_custom_SponsorMember_custom_HONGKONGMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALAC:HONGKONGMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-02to2018-12-28_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-02</xbrli:startDate>
        <xbrli:endDate>2018-12-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-19_custom_SponsorMember_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-19</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-21_custom_SponsorMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-20_custom_SponsorMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-02-16to2018-12-31_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-02-16</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-02-16to2018-12-31_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-02-16</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-01to2018-11-20_custom_SponsorMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2018-11-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-02-16to2018-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-02-16</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-02-15_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-02-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-02-16to2018-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-02-16</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-02-15_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-02-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-02-16to2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-02-16</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_SponsorMember_us-gaap_PrivatePlacementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_SponsorMember_custom_HONGKONGMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ALAC:HONGKONGMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_SponsorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">ALAC:SponsorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_MoneyMarketFundsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_USTreasurySecuritiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_NoteWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:NoteWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-20_us-gaap_OverAllotmentOptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-08-15to2018-08-31_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ALAC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-08-15</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_custom_FounderSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ALAC:FounderSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-08-15to2018-08-31_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-08-15</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-02to2018-09-10_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-02</xbrli:startDate>
        <xbrli:endDate>2018-09-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-09-10_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-09-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-02to2018-09-14_us-gaap_IPOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-02</xbrli:startDate>
        <xbrli:endDate>2018-09-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-14">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001748621</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-14</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2019-01-01to2019-03-31">Alberton Acquisition Corp</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2019-01-01to2019-03-31">0001748621</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2019-01-01to2019-03-31">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2019-01-01to2019-03-31">2019-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2019-01-01to2019-03-31">false</dei:AmendmentFlag>
    <dei:EntityFilerCategory contextRef="From2019-01-01to2019-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">5000004</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-02-15" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">5000001</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-02-15_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">4658296</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">4123281</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-02-15_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">341708</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">876720</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-03-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-03-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockValueOutstanding contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValueOutstanding contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">535012</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">535012</us-gaap:NetIncomeLoss>
    <dei:EntityEmergingGrowthCompany contextRef="From2019-01-01to2019-03-31">true</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness contextRef="From2019-01-01to2019-03-31">true</dei:EntitySmallBusiness>
    <dei:EntityExTransitionPeriod contextRef="From2019-01-01to2019-03-31">false</dei:EntityExTransitionPeriod>
    <dei:CurrentFiscalYearEndDate contextRef="From2019-01-01to2019-03-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2019-01-01to2019-03-31">2019</dei:DocumentFiscalYearFocus>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember" unitRef="Shares" decimals="INF">10000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-11-01to2018-11-20_us-gaap_IPOMember" unitRef="Shares" decimals="INF">1487992</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="Shares" decimals="INF">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-02-16to2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-08-15to2018-08-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-09-02to2018-09-10_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">1150000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2018-10-01to2018-10-26_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="0">3000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2018-11-01to2018-11-20_custom_SponsorMember_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="0">3297600</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">2379</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2018-09-05_custom_SponsorMember" unitRef="USD" decimals="0">256</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2018-09-05_custom_SponsorMember_custom_HONGKONGMember" unitRef="USD" decimals="0">1985</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2018-10-19_custom_SponsorMember_us-gaap_IPOMember" unitRef="USD" decimals="0">71000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2019-03-31_custom_SponsorMember_custom_HONGKONGMember" unitRef="USD" decimals="0">22000</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:DueToRelatedPartiesCurrent contextRef="AsOf2019-03-31_custom_SponsorMember" unitRef="USD" decimals="0">2818</us-gaap:DueToRelatedPartiesCurrent>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2018-07-02to2018-07-06_custom_SponsorMember" unitRef="USD" decimals="0">2818</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2018-12-02to2018-12-28_custom_SponsorMember" unitRef="USD" decimals="0">256</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2018-07-06_custom_SponsorMember_us-gaap_IPOMember" unitRef="USD" decimals="0">300000</us-gaap:NotesPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2019-01-01to2019-03-31" unitRef="Shares" decimals="INF">10593284</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2018-08-15to2018-08-31_custom_FounderSharesMember" unitRef="Shares" decimals="INF">375000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2018-09-02to2018-09-14_us-gaap_IPOMember" unitRef="Shares" decimals="INF">2875000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2018-12-31_us-gaap_NoteWarrantMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <dei:TradingSymbol contextRef="From2019-01-01to2019-03-31">ALAC</dei:TradingSymbol>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2018-08-15to2018-08-31_custom_FounderSharesMember" unitRef="Shares" decimals="INF">1650000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions contextRef="From2018-09-02to2018-09-10_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">1135000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-08-15to2018-08-31_custom_FounderSharesMember" unitRef="USD" decimals="0">17250</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2018-09-02to2018-09-10_us-gaap_CommonClassBMember" unitRef="USD" decimals="0">2300</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2018-08-31_custom_FounderSharesMember" unitRef="USDPShares" decimals="INF">0.010454545</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2018-09-10_us-gaap_CommonClassBMember" unitRef="USDPShares" decimals="INF">0.00202643</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2018-11-01to2018-11-20_custom_FounderSharesMember" unitRef="Shares" decimals="INF">3002</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:EscrowDeposit contextRef="AsOf2018-10-21_custom_SponsorMember_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="0">3299979</us-gaap:EscrowDeposit>
    <ALAC:CashAndInvestmentHeldInTrustAccountTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 6 &amp;#8212; Cash and Investments&#13;Held in Trust Account&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of March 31, 2019 and December 31, 2018,&#13;investments in the Company's Trust Account consisted of $597 and $31,335 in United States Money Market funds and $116,012,264&#13;and $114,848,797 in U.S. Treasury Securities, respectively. The Company classifies its United States Treasury and equivalent securities&#13;as held-to-maturity in accordance with FASB ASC 320 "Investments &amp;#8212; Debt and Equity Securities." Held-to-maturity&#13;treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion&#13;of premiums or discounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The gross holding gains and fair value&#13;of held-to-maturity securities at March 31, 2019 and December 31, 2018 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortized Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br /&gt; Holding&lt;br /&gt; Gain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold"&gt;March 31, 2019&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 64%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;U.S. Money Market&lt;/td&gt;&lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;597&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;597&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;U.S. Treasury Securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;116,012,264&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;116,019,726&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;116,012,861&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,462&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;116,020,323&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-indent: -10pt; padding-left: 10pt"&gt;December 31, 2018&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;U.S. Money Market&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;31,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;31,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;U.S. Treasury Securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;114,848,797&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;444,119&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;115,292,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;114,880,132&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;444,119&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;115,324,251&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ALAC:CashAndInvestmentHeldInTrustAccountTextBlock>
    <ALAC:CarryingValueExcludingGrossUnrealizedHoldingLossAndFairValueOfHeldToMaturitySecuritiesTableTextBlock contextRef="From2019-01-01to2019-03-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Amortized Cost&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Gross&lt;br /&gt; Holding&lt;br /&gt; Gain&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Fair Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold"&gt;March 31, 2019&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 64%; text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;U.S. Money Market&lt;/td&gt;&lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;597&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;597&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;U.S. Treasury Securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;116,012,264&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,462&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;116,019,726&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;116,012,861&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;7,462&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;116,020,323&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-indent: -10pt; padding-left: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-indent: -10pt; padding-left: 10pt"&gt;December 31, 2018&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; text-indent: -10pt; padding-left: 10pt"&gt;U.S. Money Market&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;31,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#8212;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;31,335&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"&gt;U.S. Treasury Securities&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;114,848,797&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;444,119&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;115,292,916&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 4pt; text-indent: -10pt; padding-left: 10pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;114,880,132&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;444,119&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;115,324,251&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ALAC:CarryingValueExcludingGrossUnrealizedHoldingLossAndFairValueOfHeldToMaturitySecuritiesTableTextBlock>
    <us-gaap:TradingSecuritiesUnrealizedHoldingLoss contextRef="From2018-02-16to2018-12-31" unitRef="USD" decimals="0">444119</us-gaap:TradingSecuritiesUnrealizedHoldingLoss>
    <us-gaap:TradingSecuritiesUnrealizedHoldingLoss contextRef="From2018-02-16to2018-12-31_us-gaap_MoneyMarketFundsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:TradingSecuritiesUnrealizedHoldingLoss contextRef="From2018-02-16to2018-12-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">444119</us-gaap:TradingSecuritiesUnrealizedHoldingLoss>
    <us-gaap:TradingSecuritiesUnrealizedHoldingLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">7462</us-gaap:TradingSecuritiesUnrealizedHoldingLoss>
    <us-gaap:TradingSecuritiesUnrealizedHoldingLoss contextRef="From2019-01-01to2019-03-31_us-gaap_MoneyMarketFundsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:TradingSecuritiesUnrealizedHoldingLoss contextRef="From2019-01-01to2019-03-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">7462</us-gaap:TradingSecuritiesUnrealizedHoldingLoss>
    <ALAC:CashAndInvestmentHeldInTrustAccountCarryingValue contextRef="AsOf2018-12-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">114848797</ALAC:CashAndInvestmentHeldInTrustAccountCarryingValue>
    <ALAC:CashAndInvestmentHeldInTrustAccountCarryingValue contextRef="AsOf2019-03-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">116012264</ALAC:CashAndInvestmentHeldInTrustAccountCarryingValue>
    <ALAC:InvestmentInCompanysTrustAccount contextRef="AsOf2018-12-31_us-gaap_MoneyMarketFundsMember" unitRef="USD" decimals="0">31335</ALAC:InvestmentInCompanysTrustAccount>
    <ALAC:InvestmentInCompanysTrustAccount contextRef="AsOf2018-12-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">114848797</ALAC:InvestmentInCompanysTrustAccount>
    <ALAC:InvestmentInCompanysTrustAccount contextRef="AsOf2019-03-31_us-gaap_MoneyMarketFundsMember" unitRef="USD" decimals="0">597</ALAC:InvestmentInCompanysTrustAccount>
    <ALAC:InvestmentInCompanysTrustAccount contextRef="AsOf2019-03-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">116012264</ALAC:InvestmentInCompanysTrustAccount>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 7 &amp;#8212; Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Registration Rights&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to a registration rights agreement&#13;entered into on October 23, 2018, the holders of the founder shares, Private Units (and underlying securities) and units that may&#13;be issued in payment of Working Capital Loans (and all underlying securities) are entitled to registration rights. The holders&#13;of a majority-in-interest of these securities are entitled to make up to two demands that the Company register such securities.&#13;In addition, the holders have certain "piggy-back" registration rights with respect to registration statements filed&#13;subsequent to the consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing&#13;of any such registration statements.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Deferred Underwriter Commission&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is obligated to pay the underwriters&#13;a deferred underwriting discounts and commissions equal to 3.5% of the gross proceeds of the Initial Public Offering. Upon completion&#13;of the Business Combination, $4,020,797 (with consideration of the underwriters' exercise of their over-allotment option&#13;on November 20, 2018) will be paid to the underwriters from the funds held in the Trust Account. No discounts or commissions will&#13;be paid with respect to the purchase of the private units.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <ALAC:PercentageOfUnderwritingDiscount contextRef="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember" unitRef="Pure" decimals="INF">0.035</ALAC:PercentageOfUnderwritingDiscount>
    <us-gaap:InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions contextRef="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">4020797</us-gaap:InvestmentBankingAdvisoryBrokerageAndUnderwritingFeesAndCommissions>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">4086448</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">4096466</us-gaap:CommonStockSharesIssued>
    <us-gaap:EarningsPerShareTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 9 &amp;#8212; Reconciliation of Loss&#13;per Ordinary Share&lt;/b&gt; &amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company's net income (loss) is&#13;adjusted for the portion of income that is attributable to ordinary shares subject to possible redemption, as these shares only&#13;participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss&#13;per share is:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Three Months&lt;br /&gt;&#13; March&amp;#160;31,&lt;br /&gt;&#13; 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 88%; text-align: left; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Net income&lt;/td&gt;&lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;535,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -6.5pt; padding-left: 6.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Less: income attributable to ordinary shares subject to possible redemption &lt;sup&gt;(1)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(634,967&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Adjusted net loss&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(99,955&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 4pt; text-indent: -6.5pt; padding-left: 6.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding &lt;sup&gt;(2)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,086,448&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Basic and diluted net loss per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.02&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0.25in; padding-right: 0.8pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income attributable to ordinary shares subject to possible redemption was calculated in portion of the interest income earned in Trust Account, which would be distributed to shareholders in the event they choose to exercise their redemption rights at the closing of a Business Combination.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 0.8pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Excludes an aggregate of up to 10,593,284 shares subject to possible redemption at March 31, 2019. &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2019-01-01to2019-03-31">&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Three Months&lt;br /&gt;&#13; March&amp;#160;31,&lt;br /&gt;&#13; 2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 88%; text-align: left; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Net income&lt;/td&gt;&lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;535,012&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt; text-indent: -6.5pt; padding-left: 6.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Less: income attributable to ordinary shares subject to possible redemption &lt;sup&gt;(1)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(634,967&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Adjusted net loss&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(99,955&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 4pt; text-indent: -6.5pt; padding-left: 6.5pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares outstanding &lt;sup&gt;(2)&lt;/sup&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;4,086,448&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 4pt; text-indent: -6.5pt; padding-left: 6.5pt"&gt;Basic and diluted net loss per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 4pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;(0.02&lt;/td&gt;&lt;td style="padding-bottom: 4pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 0.25in; padding-right: 0.8pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income attributable to ordinary shares subject to possible redemption was calculated in portion of the interest income earned in Trust Account, which would be distributed to shareholders in the event they choose to exercise their redemption rights at the closing of a Business Combination.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="padding-right: 0.8pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Excludes an aggregate of up to 10,593,284 shares subject to possible redemption at March 31, 2019. &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <ALAC:IncomeAttributableToOrdinarySharesSubjectToRedemption contextRef="From2019-01-01to2019-03-31" unitRef="USD" id="Foot-00-0" decimals="0">634967</ALAC:IncomeAttributableToOrdinarySharesSubjectToRedemption>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">535012</us-gaap:ProfitLoss>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 10 &amp;#8212; Subsequent Events&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company's management reviewed&#13;all material events that have occurred after the balance sheet date through the date which these financial statements were issued.&#13;Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in&#13;the financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2019-05-14" unitRef="Shares" decimals="INF">14689750</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">10603302</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">10593284</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">10.04</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">10.10</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">4086448</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">4096466</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesSubscribedButUnissued contextRef="AsOf2018-11-20_custom_SponsorMember_us-gaap_PrivatePlacementMember" unitRef="Shares" decimals="INF">329760</us-gaap:CommonStockSharesSubscribedButUnissued>
    <ALAC:InitialPublicOfferingTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 3 &amp;#8212; Initial Public Offering&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Public Units&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Pursuant to the Initial Public Offering&#13;on October 26, 2018, the Company sold 10,000,000 Units at a purchase price of $10.00 per Unit. On November 20, 2018, in connection&#13;with the underwriters' exercise of their over-allotment option, the Company consummated the sale of an additional 1,487,992&#13;Public Units at $10.00 per Unit. Each Unit consists of one ordinary share, one redeemable warrant ("Public Warrant"),&#13;and one right ("Public Right"). Each whole redeemable warrant entitles the holder to purchase one half of one ordinary&#13;share at an exercise price of $11.50 (see Note 7). No fractional Public Warrants will be issued upon separation of the Units and&#13;only whole Public Warrants will trade. Every 10 Public Rights will convert automatically into one ordinary share upon consummation&#13;of a Business Combination (see Note 7).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the Company does not complete its Business&#13;Combination within the necessary time period described in Note 1, the Public Warrants and Public Rights will expire and be worthless.&#13;Since the Company is not required to net cash settle the Public Warrants and Public Rights, and the Public Warrants and Public&#13;Rights are convertible upon the consummation of the Business Combination, management determined that the Public Warrants and Public&#13;Rights are classified within shareholders' equity as "Additional paid-in capital" upon their issuance in accordance&#13;with ASC 815-40. The proceeds from the sale are allocated to Public Shares and Public Warrants and Public Rights based on the relative&#13;fair value of the securities in accordance with ASC 470-20-30. The value of the Public Shares, Public Warrants and Public Rights&#13;was based on the closing price paid by investors.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At the closing of the Initial Public Offering&#13;and over-allotment option, the Company paid an upfront underwriting discount of $2,000,000 and $297,598, 2.0% of the per unit offering&#13;price to the underwriter, respectively, with an additional fee of $3,500,000 and $520,797 (the "Deferred Discount"),&#13;3.5% of the gross offering proceeds payable upon the completion of the Business Combination, respectively. The Deferred Discount&#13;will become payable to the underwriter from the amounts held in the Trust Account solely in the event the Company completes its&#13;Business Combination. In the event that the Company does not close a Business Combination, the underwriter has waived its right&#13;to receive the Deferred Discount. The underwriter is not entitled to any interest accrued on the Deferred Discount. Total offering&#13;costs were $3,060,924, which consist of $2,297,598 of underwriter's commissions and $763,325 of other offering costs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&lt;i&gt;Purchase Option&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On October 26, 2018, the Company sold the&#13;underwriter (and its designees), for $100, an option to purchase up to 500,000 Units exercisable at $11.50 per Unit (or an aggregate&#13;exercise price of $5,750,000) commencing on the consummation of a Business Combination. The purchase option may be exercised for&#13;cash or on a cashless basis, at the holder's option, and expires five years from the effective date of the registration statement&#13;related to the Initial Public Offering. The Units issuable upon exercise of this option are identical to those offered in the Initial&#13;Public Offering, with 500,000 ordinary shares, warrants to purchase 250,000 shares and rights to receive 50,000 ordinary shares&#13;that may be issued upon exercise of the option.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounted for the unit purchase&#13;option, inclusive of the receipt of $100 cash payment, as an expense of the Initial Public Offering resulting in a charge directly&#13;to shareholders' equity. The Company estimated the fair value of this unit purchase option to be approximately $1,603,060&#13;(or $3.206 per Unit) using the Black-Scholes option-pricing model. The fair value of the unit purchase option granted to the underwriters&#13;was estimated as of the date of grant using the following assumptions: (1) expected volatility of 38%, (2) risk-free interest rate&#13;of 2.29% (the interest rate on a three-month US Treasury Bill on October 26, 2018) and (3) expected life of five years.&lt;/p&gt;</ALAC:InitialPublicOfferingTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 8 &amp;#8212; Shareholder's Equity&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Preferred Shares&lt;/b&gt; - The Company is&#13;authorized to issue 100,000,000 shares of no par value preferred shares, with such designation, rights and preferences as may be&#13;determined from time to time by the Company's board of directors. As of March 31, 2019 and December 31, 2018, there are no&#13;preferred shares designated, issued or outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Ordinary Shares&lt;/b&gt; - The Company is&#13;authorized to issue 300,000,000 ordinary shares, no par value. As of March 31, 2019 and December 31, 2018, the Company had issued&#13;an aggregate of 4,096,466 and 4,086,448 ordinary shares, excluding 10,593,284 and 10,603,302 shares of ordinary shares subject&#13;to possible redemption, respectively.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Warrants&lt;/b&gt; - Each warrant entitles&#13;the registered holder to purchase one-half (1/2) of one ordinary share at a price of $11.50 per whole ordinary share, subject to&#13;adjustment as discussed below, at any time commencing on the later of the completion of the Business Combination or 12 months from&#13;the date of the effective date of the registration statement. However, no warrants will be exercisable for cash unless the Company&#13;has an effective and current registration statement covering the ordinary shares issuable upon exercise of the warrants. Notwithstanding&#13;the foregoing, if a registration statement covering the ordinary shares issuable upon exercise of the public warrants is not effective&#13;within a specified period following the consummation of the Company's Business Combination, warrant holders may, until such&#13;time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective&#13;registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities&#13;Act, provided that such exemption is available. In such event, each holder would pay the exercise price by surrendering the warrants&#13;for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares&#13;underlying the warrants, multiplied by the difference between the exercise price of the warrants and the "fair market value"&#13;(defined below) by (y) the fair market value. The "fair market value" for this purpose will mean the average reported&#13;last sale price of the ordinary shares for the 20 trading days ending on the third trading day immediately prior to the date of&#13;exercise. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless&#13;basis. The warrants will expire on the fifth anniversary of the closing of the initial business combination, at 5:00 p.m., New&#13;York City time, or earlier upon redemption or liquidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The warrants issued in the Private Units&#13;("Private Warrants") are identical to the Public Warrants sold in the Initial Public Offering except the Private Warrants&#13;will be non-redeemable and may be exercised on a cashless basis, in each case so long as they continue to be held by the initial&#13;purchasers or their permitted transferees.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company may call the warrants for redemption&#13;(excluding the private warrants and any warrants issued to its initial shareholders, officers or directors in payment of working&#13;capital loans made to the Company, but including outstanding warrants issued upon exercise of the unit purchase option issued to&#13;Chardan Capital Markets LLC), in whole and not in part, at a price of $0.01 per warrant,&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 3%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 0.8pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 94%; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;at any time after the warrants become exercisable,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 3%; padding-right: 0.8pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 0.8pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 94%; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;upon not less than 30 days' prior written notice of redemption to each warrant holder,&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 3%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 0.8pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 94%; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;if, and only if, the reported last sale price of the ordinary shares equals or exceeds $16.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third business day prior to the notice of redemption to warrant holders; and&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 3%; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 3%; padding-right: 0.8pt"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#9679;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 94%; padding-right: 0.8pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants.&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The right to exercise will be forfeited&#13;unless the warrants are exercised prior to the date specified in the notice of redemption. On and after the redemption date, a&#13;record holder of a warrant will have no further rights except to receive the redemption price for such holder's warrant upon&#13;surrender of such warrant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the Company calls the warrants for redemption&#13;as described above, management will have the option to require all holders that wish to exercise warrants to do so on a "cashless&#13;basis."&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Rights&lt;/b&gt; - Each holder of a right&#13;will receive one-tenth (1/10) of one ordinary share upon consummation of a Business Combination, even if a holder of such right&#13;converted all ordinary shares held by it in connection with a Business Combination. No fractional shares will be issued upon exchange&#13;of the rights. No additional consideration will be required to be paid by a holder of rights to receive its additional shares upon&#13;consummation of a Business Combination as the consideration related thereto has been included in the Unit purchase price paid for&#13;by investors in the Initial Public Offering. If the Company enters into a definitive agreement for a Business Combination in which&#13;the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same&#13;per share consideration the holders of the ordinary shares will receive in the transaction on an as-converted into ordinary shares&#13;basis and each holder of rights will be required to affirmatively covert its rights in order to receive 1/10 of a share underlying&#13;each right (without paying additional consideration). The shares issuable upon exchange of the rights will be freely tradable (except&#13;to the extent held by affiliates of the Company).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the Company is unable to complete a&#13;Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of rights&#13;will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company's&#13;assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are&#13;no contractual penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination.&#13;Additionally, in no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The rights included in the Private Units&#13;sold in the private placement are identical to the rights included in the Units sold in the Initial Public Offering, except that,&#13;among others, the rights including the shares issuable upon exchange of such rights, are being purchased pursuant to an exemption&#13;from the registration requirements of the Securities Act and will become tradable only after certain conditions are met or the&#13;resale of such rights (including underlying securities) is registered under the Securities Act. Please refer to Note 5 Private&#13;Placement for more details.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <dei:DocumentFiscalPeriodFocus contextRef="From2019-01-01to2019-03-31">Q1</dei:DocumentFiscalPeriodFocus>
    <us-gaap:Assets contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">115790422</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">116317035</us-gaap:Assets>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">115324251</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">116012861</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">466171</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">304174</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">13762</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">7415</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:Cash contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">452409</us-gaap:Cash>
    <us-gaap:Cash contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">296759</us-gaap:Cash>
    <us-gaap:Liabilities contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">4333265</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">4324866</us-gaap:Liabilities>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">4020797</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">4020797</us-gaap:LiabilitiesOtherThanLongtermDebtNoncurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">312468</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">304069</us-gaap:LiabilitiesCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">300000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">300000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">10089</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">4069</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">106457153</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">106992168</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">115790422</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">116317035</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">341708</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">876720</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CommonStockValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">4658296</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">4123281</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-153741</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingCostsAndExpenses contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">153741</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-03-31" unitRef="USDPShares" decimals="INF">-0.02</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-03-31" unitRef="Shares" id="Foot-01-0" decimals="INF">4086448</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-99955</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">634967</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">688753</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InvestmentIncomeInterest contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">688610</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestIncomeOther contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">143</us-gaap:InterestIncomeOther>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-02-15_us-gaap_CommonStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">4086448</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">4096466</us-gaap:SharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-02-16to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-02-16to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-02-16to2018-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">10018</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-535015</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">-535015</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <ALAC:InterestEarnedOnInvestmentHeldInTrustAccount contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">688610</ALAC:InterestEarnedOnInvestmentHeldInTrustAccount>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-6347</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-2379</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-6020</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">452409</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">296759</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashPeriodIncreaseDecrease contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-155650</us-gaap:CashPeriodIncreaseDecrease>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-155650</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <ALAC:ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">535015</ALAC:ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 1 &amp;#8212; Organization and Business&#13;Operations&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Organization and General&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Alberton Acquisition Corporation (the "Company")&#13;is a blank check company incorporated on February 16, 2018, under the laws of British Virgin Islands for the purpose of entering&#13;into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination&#13;with one or more businesses or entities (a "Business Combination"). The Company's efforts to identify a prospective&#13;target business will not be limited to an industry or geographic location.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;As of March 31, 2019, the Company had not&#13;yet commenced any operations. The Company has selected December 31 as its fiscal year end.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Financing&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The registration statement for the Company's&#13;initial public offering (the "Initial Public Offering" as described in Note 3) was declared effective by the United&#13;States Securities and Exchange Commission ("SEC") on October 23, 2018. On October 26, 2018, the Company consummated&#13;the Initial Public Offering of 10,000,000 units at $10.00 per unit ("Units" or "Public Units" and, with&#13;respect to the ordinary shares included in the Public Units offered, the "Public Shares"), generating gross proceeds&#13;of $100,000,000, which is described in Note 3.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Simultaneously with the closing of the&#13;Initial Public Offering, the Company consummated the sale of 300,000 units (the "Private Units") at a price of $10.00&#13;per Unit in a private placement to the Company's sponsor (the "Sponsor"), generating gross proceeds of $3,000,000,&#13;which is described in Note 4.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On November 20, 2018, the underwriters&#13;exercised the over-allotment option in part and purchased 1,487,992 Public Units, which were sold at an offering price of $10.00&#13;per Unit, generating gross proceeds of $14,879,920. Simultaneously with the sale of the over-allotment Public Units, the Company&#13;consummated the private placement of an additional 29,760 Private Units at a price of $10.00 per Unit, generating total additional&#13;gross proceeds of $297,600.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Trust Account&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Following the closing of the Initial Public&#13;Offering on October 26, 2018, an amount of $100,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Public Units&#13;in the Initial Public Offering and the Private Units was placed in a trust account ("Trust Account"). Following the&#13;closing of underwriters' exercise of over-allotment option on November 20, 2018, an additional $14,879,920 of net proceeds&#13;($10.00 per Unit) was placed in the Trust Account, bringing the aggregate proceeds held in the Trust Account to $114,879,920.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The funds in the Trust Account are invested&#13;in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended&#13;(the "Investment Company Act"), with a maturity of 180 days or less or in any open-ended investment company that holds&#13;itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company,&#13;until the earlier of: (i) the consummation of a Business Combination or (ii) the Company's failure to consummate a Business&#13;Combination by October 26, 2019 (or April 26, 2020 if the Company fully extends the period of time to consummate a Business Combination).&#13;Placing funds in the Trust Account may not protect those funds from third party claims against the Company. Although the Company&#13;will seek all vendors, service providers, prospective target businesses or other entities it engages, to execute agreements with&#13;the Company waiving any claim of any kind in or to any monies held in the Trust Account, there is no guarantee that such persons&#13;will execute such agreements. The remaining net proceeds (not held in the Trust Account) may be used to pay for business, legal&#13;and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. Additionally, the&#13;interest earned on the Trust Account balance may be released to the Company to pay the Company's tax obligations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Business Combination&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company's management has broad&#13;discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the Private Units,&#13;although substantially all the net proceeds are intended to be generally applied toward consummating a Business Combination. The&#13;Company's Business Combination must be with one or more target businesses that together have a fair market value equal to&#13;at least 80% of the balance in the Trust Account (excluding any deferred underwriter's fees and taxes payable on the income&#13;earned on the Trust Account), which the Company refers to as the 80% test,&amp;#160;at the time of the signing of an agreement to&#13;enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination&#13;company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest&#13;in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There&#13;is no assurance that the Company will be able to successfully effect a Business Combination. If less than 100% of the equity interests&#13;or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business&#13;or businesses that is owned or acquired is what will be valued for purposes of the 80% test.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company will provide its shareholders&#13;with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i)&#13;in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision&#13;as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the&#13;Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount&#13;then on deposit in the Trust Account ($10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account&#13;and not previously released to the Company to pay its tax obligations).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company will proceed with a Business&#13;Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and&#13;a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. If a shareholder vote is&#13;not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company&#13;will, pursuant to Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer&#13;rules of the Securities and Exchange Commission ("SEC"), and file tender offer documents with the SEC prior to completing&#13;a Business Combination. If, however, a shareholder approval of the transaction is required by law, or the Company decides to obtain&#13;shareholder approval for business or other legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation&#13;pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection&#13;with a Business Combination, the Initial Shareholders (defined in Note 5 - Related Party Transactions) have agreed to vote their&#13;initial shares and private shares, as well as any Public Shares acquired in or after the Initial Public Offering, in favor of any&#13;proposed Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether&#13;they vote for or against the proposed transaction.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The amount in the Trust Account (less the&#13;aggregate nominal par value of the shares of the Company's public shareholders) under the Companies Law will be treated as&#13;share premium which is distributable under the Companies Law provided that immediately following the date on which the proposed&#13;distribution is proposed to be made, the Company is able to pay the debts as they fall due in the ordinary course of business.&#13;If the Company is forced to liquidate the Trust Account, the public shareholders would be distributed the amount in the Trust Account&#13;calculated as of the date that is two days prior to the distribution date (including any accrued interest).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Initial Shareholders have agreed to&#13;(i) vote their insider shares (as well as any Public Shares acquired in or after the Initial Public Offering) in favor of any proposed&#13;Business Combination, (ii) waive their conversion rights with respect to their initial share (as well as any other shares acquired&#13;in or after the Initial Public Offering) in connection with the consummation of a Business Combination, (iii) waive their rights&#13;to liquidating distributions from the Trust Account with respect to their initial shares if the Company fails to consummate a Business&#13;Combination within the Combination Period, and (iv) not propose an amendment to the Company's Amended and Restated Memorandum&#13;and Articles of Association that would affect the substance or timing of the Company's obligation to redeem 100% of its Public&#13;Shares if the Company does not complete a Business Combination, unless the Company provides the public shareholders with the opportunity&#13;to redeem their shares in conjunction with any such amendment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Liquidation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the Company anticipates that it may&#13;not be able to consummate the Business Combination by October 26, 2019, it may, but is not obligated to, extend the period to consummate&#13;a Business Combination two times by an additional three months each time (for a total of up to 18&amp;#160;months to complete a Business&#13;Combination). Pursuant to the terms of the Company's Amended and Restated Memorandum and Articles of Association and the&#13;trust agreement entered into between the Company and Continental Stock Transfer &amp;#38; Trust Company, in order to extend the time&#13;available for the Company to consummate the Business Combination, the Company's insiders or their affiliates or designees,&#13;upon five days advance notice prior to each applicable deadline, must deposit into the trust account $1,148,799 on or prior to&#13;the date of such applicable deadline. The insiders will receive a non-interest&amp;#160;bearing, unsecured promissory note equal to&#13;the amount of any such deposit that will not be repaid in the event that the Company is unable to close a Business Combination&#13;unless there are funds available outside the Trust Account to do so. Such notes would either be paid upon consummation of the Business&#13;Combination, or, at the lender's discretion, converted upon consummation of the Business Combination into additional Private&#13;Units at a price of $10.00 per unit. The Company's shareholders have approved the issuance of the Private Units upon conversion&#13;of such notes, to the extent the holder wishes to so convert such notes at the time of the consummation of the Business Combination.&#13;In the event that the Company receives notice from its insiders five days prior to an applicable deadline of their intent to effect&#13;an extension, the Company intends to issue a press release announcing such intention at least three days prior to such applicable&#13;deadline. In addition, the Company intends to issue a press release the day after such applicable deadline announcing whether the&#13;funds had been timely deposited. The Company's insiders and their affiliates or designees are not obligated to fund the Trust&#13;Account to extend the time for the Company to complete the Business Combination. To the extent that some, but not all, of the Company's&#13;insiders, decide to extend the period of time to consummate the Business Combination, such insiders (or their affiliates or designees)&#13;may deposit the entire amount required. If the Company is unable to consummate the Business Combination within such time period,&#13;the Company will, as promptly as possible but not more than ten business days thereafter, redeem 100% of its outstanding public&#13;shares for a pro rata portion of the funds held in the Trust Account and then seek to dissolve and liquidate. In such event, the&#13;public warrants and rights will expire and will be worthless.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Emerging Growth Company&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is an "emerging growth&#13;company," as defined in Section 2(a) of the Securities Act of 1933, as amended, (the "Securities Act"), as modified&#13;by the Jumpstart Our Business Startups Act of 2012, (the "JOBS Act"), and it may take advantage of certain exemptions&#13;from various reporting requirements that are applicable to other public companies that are not emerging growth companies including,&#13;but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley&#13;Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions&#13;from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute&#13;payments not previously approved.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Further, Section 102(b)(1) of the JOBS&#13;Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private&#13;companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of&#13;securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The&#13;JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply&#13;to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such&#13;extended transition period which means that when a standard is issued or revised, and it has different application dates for public&#13;or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies&#13;adopt the new or revised standard. This may make comparison of the Company's financial statements with another public company&#13;which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition&#13;period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_TrustAccountMember" unitRef="USD" decimals="0">100000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember" unitRef="USD" decimals="0">100000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">14879920</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember_custom_TrustAccountMember" unitRef="USD" decimals="0">14879920</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2018-10-01to2018-10-26_us-gaap_PrivatePlacementMember" unitRef="Shares" decimals="INF">300000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember" unitRef="Shares" decimals="INF">1487992</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember_custom_TrustAccountMember" unitRef="Shares" decimals="INF">1487992</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2019-01-01to2019-03-31" unitRef="Shares" decimals="INF">300000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2018-10-26_us-gaap_PrivatePlacementMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2019-03-31_us-gaap_OverAllotmentOptionMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2018-11-20_us-gaap_OverAllotmentOptionMember_custom_TrustAccountMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2018-10-26_us-gaap_IPOMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2018-11-20_us-gaap_IPOMember" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="USDPShares" decimals="INF">3.206</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction contextRef="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">297600</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:OtherIntangibleAssetsNet contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">5000001</us-gaap:OtherIntangibleAssetsNet>
    <ALAC:PercentageOfOutstandingVotingRights contextRef="From2018-02-16to2018-12-31" unitRef="Pure" decimals="INF">0.50</ALAC:PercentageOfOutstandingVotingRights>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2018-12-31" unitRef="Pure" decimals="INF">0.80</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <ALAC:PercentageOfOutstandingPublicShares contextRef="From2018-02-16to2018-12-31" unitRef="Pure" decimals="INF">1.00</ALAC:PercentageOfOutstandingPublicShares>
    <ALAC:PercentageOfOutstandingPublicShares contextRef="From2018-02-16to2018-12-31_us-gaap_IPOMember" unitRef="Pure" decimals="INF">1.00</ALAC:PercentageOfOutstandingPublicShares>
    <us-gaap:ProceedsFromSaleOfTrustAssetsToPayExpenses contextRef="From2018-11-01to2018-11-20_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">114879920</us-gaap:ProceedsFromSaleOfTrustAssetsToPayExpenses>
    <us-gaap:ProceedsFromSaleOfTrustAssetsToPayExpenses contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">1148799</us-gaap:ProceedsFromSaleOfTrustAssetsToPayExpenses>
    <us-gaap:CashFDICInsuredAmount contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">250000</us-gaap:CashFDICInsuredAmount>
    <invest:InvestmentWarrantsExercisePrice contextRef="From2018-11-01to2018-11-20_us-gaap_IPOMember" unitRef="USDPShares" decimals="INF">11.50</invest:InvestmentWarrantsExercisePrice>
    <invest:InvestmentWarrantsExercisePrice contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="USDPShares" decimals="INF">11.50</invest:InvestmentWarrantsExercisePrice>
    <ALAC:WarrantDescription contextRef="From2018-11-01to2018-11-20_us-gaap_IPOMember">Every 10 Public Rights will convert automatically into one ordinary share upon consummation of a Business Combination.</ALAC:WarrantDescription>
    <ALAC:UpfrontUnderwritingDiscount contextRef="AsOf2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">2000000</ALAC:UpfrontUnderwritingDiscount>
    <ALAC:OfferingPriceToUnderwriter contextRef="AsOf2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">297598</ALAC:OfferingPriceToUnderwriter>
    <ALAC:UnderwritingPriceRatio contextRef="From2018-11-01to2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember" unitRef="Pure" decimals="INF">0.020</ALAC:UnderwritingPriceRatio>
    <ALAC:AdditionalFeeToUnderwriter contextRef="AsOf2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">3500000</ALAC:AdditionalFeeToUnderwriter>
    <ALAC:DeferredDiscountGrossOfferingProceeds contextRef="AsOf2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">520797</ALAC:DeferredDiscountGrossOfferingProceeds>
    <ALAC:PercentageOfDeferredDiscountGrossOfferingProceeds contextRef="AsOf2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember" unitRef="Pure" decimals="INF">0.035</ALAC:PercentageOfDeferredDiscountGrossOfferingProceeds>
    <ALAC:TotalOfferingCosts contextRef="AsOf2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">3060924</ALAC:TotalOfferingCosts>
    <us-gaap:PaymentsForCommissions contextRef="From2018-11-01to2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">2297598</us-gaap:PaymentsForCommissions>
    <ALAC:OtherOfferingCosts contextRef="AsOf2018-11-20_us-gaap_IPOMember_us-gaap_OverAllotmentOptionMember" unitRef="USD" decimals="0">763325</ALAC:OtherOfferingCosts>
    <ALAC:UnderwritersFees contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="USD" decimals="0">100</ALAC:UnderwritersFees>
    <ALAC:AggregateExercisePrice contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="USD" decimals="0">5750000</ALAC:AggregateExercisePrice>
    <ALAC:OptionToPurchaseOrdinaryShares contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="Shares" decimals="INF">500000</ALAC:OptionToPurchaseOrdinaryShares>
    <ALAC:WarrantsToPurchaseSharesAndRights contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="Shares" decimals="INF">250000</ALAC:WarrantsToPurchaseSharesAndRights>
    <ALAC:OrdinarySharesIssuedUponExerciseOfOption contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="Shares" decimals="INF">50000</ALAC:OrdinarySharesIssuedUponExerciseOfOption>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="USD" decimals="0">100</us-gaap:PaymentsOfStockIssuanceCosts>
    <ALAC:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStock contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="USD" decimals="0">1603060</ALAC:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStock>
    <ALAC:FairValueAssumptionExpectedVolatilityRate contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="Pure" decimals="INF">0.38</ALAC:FairValueAssumptionExpectedVolatilityRate>
    <ALAC:FairValueAssumptionRiskFreeInterestRate contextRef="From2018-10-01to2018-10-26_us-gaap_IPOMember_custom_PurchaseOptionMember" unitRef="Pure" decimals="INF">0.0229</ALAC:FairValueAssumptionRiskFreeInterestRate>
    <ALAC:Remainingprivateplacement contextRef="AsOf2019-03-31_custom_SponsorMember_us-gaap_PrivatePlacementMember" unitRef="USD" decimals="0">2379</ALAC:Remainingprivateplacement>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-03-31_custom_SponsorMember" unitRef="USD" decimals="0">1000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AdministrativeFeesExpense contextRef="From2019-01-01to2019-03-31_custom_SponsorMember" unitRef="USD" decimals="0">3000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:RelatedPartyTransactionDescriptionOfTransaction contextRef="From2019-01-01to2019-03-31">The Initial Shareholders have agreed not to transfer, assign or sell any of the Founder Shares (except to certain permitted transferees) until, with respect to 50% of the Founder Shares, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii) the date on which the closing price of the Company's ordinary shares equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business Combination, and with respect to the remaining 50% of the Founder Shares, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction which results in all of the Company's shareholders having the right to exchange their ordinary shares for cash, securities or other property.</us-gaap:RelatedPartyTransactionDescriptionOfTransaction>
    <ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">114880132</ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost>
    <ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost contextRef="AsOf2018-12-31_us-gaap_MoneyMarketFundsMember" unitRef="USD" decimals="0">31335</ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost>
    <ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost contextRef="AsOf2018-12-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">114848797</ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost>
    <ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">116012861</ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost>
    <ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost contextRef="AsOf2019-03-31_us-gaap_MoneyMarketFundsMember" unitRef="USD" decimals="0">597</ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost>
    <ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost contextRef="AsOf2019-03-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">116012264</ALAC:CashAndInvestmentHeldInTrustAccountAmortizedCost>
    <us-gaap:SharePrice contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">11.50</us-gaap:SharePrice>
    <us-gaap:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstanding contextRef="From2019-01-01to2019-03-31_us-gaap_NoteWarrantMember">The Company may call the warrants for redemption (excluding the private warrants and any warrants issued to its initial shareholders, officers or directors in payment of working capital loans made to the Company, but including outstanding warrants issued upon exercise of the unit purchase option issued to Chardan Capital Markets LLC), in whole and not in part, at a price of $0.01 per warrant, &#9679; at any time after the warrants become exercisable, &#9679; upon not less than 30 days' prior written notice of redemption to each warrant holder, &#9679; if, and only if, the reported last sale price of the ordinary shares equals or exceeds $16.00 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations), for any 20 trading days within a 30 trading day period ending on the third business day prior to the notice of redemption to warrant holders; and &#9679; if, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants.</us-gaap:ClassOfWarrantOrRightTitleOfSecurityWarrantsOrRightsOutstanding>
    <ALAC:WeightedAverageNumberOfSharesOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-03-31" unitRef="Shares" id="Foot-02-0" decimals="INF">4086448</ALAC:WeightedAverageNumberOfSharesOutstandingBasicAndDiluted>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 2 &amp;#8212; Significant Accounting&#13;Policies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial&#13;statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United&#13;States of America ("US GAAP") and pursuant to the accounting and disclosure rules and regulations of the SEC. The unaudited&#13;condensed interim accompanying financial statements have been prepared in accordance with US GAAP for interim financial statements&#13;and Article 8 of Regulation S-X. They do not include all of the information and notes required by US GAAP for complete financial&#13;statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are&#13;necessary to present fairly the financial position, and the results of its operations and its cash flows. Operating results as&#13;presented are not necessarily indicative of the results to be expected for a full year. The unaudited condensed financial statements&#13;should be read in conjunction with the audited financial statements and the notes thereto for the fiscal year ended December 31,&#13;2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company had no activity for the period&#13;from February 16, 2018 (inception) through March 31, 2018. Accordingly, the condensed statement of operations and condensed statement&#13;of cash flow for the comparative period from February 16, 2018 (inception) through March 31, 2018 are not presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements&#13;in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and&#13;liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts&#13;of expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers all short-term investments&#13;with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents&#13;as of March 31, 2019 and December 31, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Investments Held in Trust Account&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At March 31, 2019 and December 31, 2018,&#13;substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Ordinary Shares Subject to Possible&#13;Redemption&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for its ordinary shares&#13;subject to possible redemption in accordance with the guidance in Accounting Standards Codification ("ASC") Topic 480&#13;"Distinguishing Liabilities from Equity." Ordinary shares subject to mandatory redemption are classified as a liability&#13;instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption&#13;rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely&#13;within the Company's control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders'&#13;equity. The Company's ordinary shares feature certain redemption rights that are considered to be outside of the Company's&#13;control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented&#13;as temporary equity, outside of the shareholders' equity section of the Company's balance sheet.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with the accounting&#13;and reporting requirements of ASC Topic 740, "Income Taxes," which requires an asset and liability approach to financial&#13;accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the&#13;financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on&#13;enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation&#13;allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC Topic 740 prescribes a recognition&#13;threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected&#13;to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon&#13;examination by taxing authorities. The Company's management determined that the British Virgin Islands is the Company's&#13;only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any,&#13;as income tax expense. There were no unrecognized tax benefits as of March 31, 2019 and no amounts accrued for interest and penalties.&#13;The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation&#13;from its position. &lt;font style="color: #010C03"&gt;The Company is subject to income tax examinations by major taxing authorities since&#13;inception.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #010C03"&gt;The Company is considered&#13;an exempted British Virgin Islands Company, and is presently not subject to income taxes or income tax filing requirements in the&#13;British Virgin Islands or the United States. As such, the Company's tax provision is zero for the period presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Net Loss per Ordinary Share&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and&#13;disclosure requirements ASC Topic 260, "Earnings Per Share." Net loss per ordinary share is computed by dividing net&#13;loss by the weighted average number of ordinary shares issued and outstanding for the period. Ordinary shares subject to possible&#13;redemption at March 31, 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from&#13;the calculation of basic and diluted loss per ordinary share since such shares, if redeemed, only participate in their pro rata&#13;share of the Trust Account earnings. At March 31, 2019, the Company did not have any dilutive securities and other contracts that&#13;could, potentially, be exercised or converted into ordinary shares and then share in the income of the Company. As a result, diluted&#13;loss per ordinary share is the same as basic loss per ordinary shares for the period presented.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially&#13;subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed&#13;the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management&#13;believes the Company is not exposed to significant risks on such accounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Company's assets&#13;and liabilities, which qualify as financial instruments under ASC Topic 820, "Fair Value Measurements and Disclosures,"&#13;approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management does not believe that any recently&#13;issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company's financial&#13;statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Basis of Presentation&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial&#13;statements of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted in the United&#13;States of America (&amp;#8220;US GAAP&amp;#8221;) and pursuant to the accounting and disclosure rules and regulations of the SEC. The unaudited&#13;condensed interim accompanying financial statements have been prepared in accordance with US GAAP for interim financial statements&#13;and Article 8 of Regulation S-X. They do not include all of the information and notes required by US GAAP for complete financial&#13;statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are&#13;necessary to present fairly the financial position, and the results of its operations and its cash flows. Operating results as&#13;presented are not necessarily indicative of the results to be expected for a full year. The unaudited condensed financial statements&#13;should be read in conjunction with the audited financial statements and the notes thereto for the fiscal year ended December 31,&#13;2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company had no activity for the period&#13;from February 16, 2018 (inception) through March 31, 2018. Accordingly, the condensed statement of operations and condensed statement&#13;of cash flow for the comparative period from February 16, 2018 (inception) through March 31, 2018 are not presented.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Use of Estimates&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of financial statements&#13;in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and&#13;liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts&#13;of expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Cash and Cash Equivalents&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company considers all short-term investments&#13;with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents&#13;as of March 31, 2019 and December 31, 2018.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <ALAC:InvestmentsHeldInTrustAccount contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Investments Held in Trust Account&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;At March 31, 2019 and December 31, 2018,&#13;substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills.&lt;/p&gt;</ALAC:InvestmentsHeldInTrustAccount>
    <ALAC:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Ordinary Shares Subject to Possible&#13;Redemption&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for its ordinary shares&#13;subject to possible redemption in accordance with the guidance in Accounting Standards Codification (&amp;#8220;ASC&amp;#8221;) Topic 480&#13;&amp;#8220;Distinguishing Liabilities from Equity.&amp;#8221; Ordinary shares subject to mandatory redemption are classified as a liability&#13;instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption&#13;rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely&#13;within the Company&amp;#8217;s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders&amp;#8217;&#13;equity. The Company&amp;#8217;s ordinary shares feature certain redemption rights that are considered to be outside of the Company&amp;#8217;s&#13;control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible redemption are presented&#13;as temporary equity, outside of the shareholders&amp;#8217; equity section of the Company&amp;#8217;s balance sheet.&lt;/p&gt;</ALAC:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Income Taxes&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with the accounting&#13;and reporting requirements of ASC Topic 740, "Income Taxes," which requires an asset and liability approach to financial&#13;accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the&#13;financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on&#13;enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation&#13;allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC Topic 740 prescribes a recognition&#13;threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected&#13;to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon&#13;examination by taxing authorities. The Company's management determined that the British Virgin Islands is the Company's&#13;only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any,&#13;as income tax expense. There were no unrecognized tax benefits as of March 31, 2019 and no amounts accrued for interest and penalties.&#13;The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation&#13;from its position. &lt;font style="color: #010C03"&gt;The Company is subject to income tax examinations by major taxing authorities since&#13;inception.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #010C03"&gt;The Company is considered&#13;an exempted British Virgin Islands Company, and is presently not subject to income taxes or income tax filing requirements in the&#13;British Virgin Islands or the United States. As such, the Company's tax provision is zero for the period presented.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Net Loss per Ordinary Share&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and&#13;disclosure requirements ASC Topic 260, &amp;#8220;Earnings Per Share.&amp;#8221; Net loss per ordinary share is computed by dividing net&#13;loss by the weighted average number of ordinary shares issued and outstanding for the period. Ordinary shares subject to possible&#13;redemption at March 31, 2019, which are not currently redeemable and are not redeemable at fair value, have been excluded from&#13;the calculation of basic and diluted loss per ordinary share since such shares, if redeemed, only participate in their pro rata&#13;share of the Trust Account earnings. At March 31, 2019, the Company did not have any dilutive securities and other contracts that&#13;could, potentially, be exercised or converted into ordinary shares and then share in the income of the Company. As a result, diluted&#13;loss per ordinary share is the same as basic loss per ordinary shares for the period presented.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Financial instruments that potentially&#13;subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed&#13;the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management&#13;believes the Company is not exposed to significant risks on such accounts.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Fair Value of Financial Instruments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Company&amp;#8217;s assets&#13;and liabilities, which qualify as financial instruments under ASC Topic 820, &amp;#8220;Fair Value Measurements and Disclosures,&amp;#8221;&#13;approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Recent Accounting Pronouncements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management does not believe that any recently&#13;issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&amp;#8217;s financial&#13;statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2019-01-01to2019-03-31">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <ALAC:PrivatePlacementsTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 4 &amp;#8212; Private Placements&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Simultaneously with the Initial Public&#13;Offering, the Company's Sponsor purchased an aggregate of 300,000 Private Units at $10.00 per Unit (for a total purchase&#13;price of $3,000,000). On November 20, 2018, in connection with the underwriters' partial exercise of their over-allotment&#13;option, the Company consummated the sale of additional 29,760 Private Units, generating gross proceeds of $297,600. The proceeds&#13;from the Private Units were added to the proceeds from the Initial Public Offering held in the Trust Account.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Private Units are identical to the&#13;units sold in the Initial Public Offering except the Private Units are non-redeemable and may be exercised on a cashless basis,&#13;in each case so long as they continue to be held by the Sponsor or its permitted transferees. The purchasers of the Private Units&#13;have agreed not to transfer, assign or sell any of the Private Units or underlying securities (except to the same permitted transferees&#13;as the founder shares) until the completion of the Business Combination.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the Company does not complete a Business&#13;Combination within the Combination Period, the proceeds of the sale of the Private Units will be used to fund the redemption of&#13;the Public Shares (subject to the requirements of applicable law).&lt;/p&gt;</ALAC:PrivatePlacementsTextBlock>
    <us-gaap:SharesIssued contextRef="AsOf2018-11-20_us-gaap_OverAllotmentOptionMember" unitRef="Shares" decimals="INF">29760</us-gaap:SharesIssued>
    <ALAC:PurchasePrice contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">3000000</ALAC:PurchasePrice>
    <ALAC:CashAndInvestmentsHeldInTrustAccountFairValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">115324251</ALAC:CashAndInvestmentsHeldInTrustAccountFairValue>
    <ALAC:CashAndInvestmentsHeldInTrustAccountFairValue contextRef="AsOf2018-12-31_us-gaap_MoneyMarketFundsMember" unitRef="USD" decimals="0">31335</ALAC:CashAndInvestmentsHeldInTrustAccountFairValue>
    <ALAC:CashAndInvestmentsHeldInTrustAccountFairValue contextRef="AsOf2018-12-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">115292916</ALAC:CashAndInvestmentsHeldInTrustAccountFairValue>
    <ALAC:CashAndInvestmentsHeldInTrustAccountFairValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">116020323</ALAC:CashAndInvestmentsHeldInTrustAccountFairValue>
    <ALAC:CashAndInvestmentsHeldInTrustAccountFairValue contextRef="AsOf2019-03-31_us-gaap_MoneyMarketFundsMember" unitRef="USD" decimals="0">597</ALAC:CashAndInvestmentsHeldInTrustAccountFairValue>
    <ALAC:CashAndInvestmentsHeldInTrustAccountFairValue contextRef="AsOf2019-03-31_us-gaap_USTreasurySecuritiesMember" unitRef="USD" decimals="0">116019726</ALAC:CashAndInvestmentsHeldInTrustAccountFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2018-08-15to2018-08-31_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">75000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2018-09-02to2018-09-10_us-gaap_CommonClassBMember" unitRef="Shares" decimals="INF">15000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <ALAC:WorkingCapitalLoans contextRef="AsOf2019-03-31_custom_SponsorMember" unitRef="USD" decimals="0">1500000</ALAC:WorkingCapitalLoans>
    <ALAC:WorkingCapitalLoansPerUnit contextRef="AsOf2019-03-31_custom_SponsorMember" unitRef="USDPShares" decimals="INF">10.00</ALAC:WorkingCapitalLoansPerUnit>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Note 5 &amp;#8212; Related Party Transactions&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Founder Shares&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In August 2018, the Company issued 1,725,000&#13;Class B ordinary shares to its initial shareholders as founder shares, of which an aggregate of 1,650,000 Class B ordinary shares&#13;were issued for an aggregate purchase price of $17,250 or 0.010454545 per share, and an aggregate of 75,000 Class B ordinary shares&#13;were issued for services rendered. On September 10, 2018, the Company issued an additional 1,150,000 Class B ordinary shares to&#13;its initial shareholders as founder shares, of which an aggregate of 1,135,000 Class B ordinary shares were issued for an aggregate&#13;purchase price of $2,300 or approximately 0.00202643 per share, and an aggregate of 15,000 Class B ordinary shares were issued&#13;for services rendered. On September 14, 2018, the Company's initial shareholders converted all of their Class B ordinary&#13;shares, constituting all of the outstanding Class B ordinary shares of the Company, into Class A ordinary shares and, immediately&#13;thereafter, the Company amended and restated its Memorandum and Articles of Association to eliminate the Class B ordinary shares&#13;and re-designate the Class A ordinary shares as "ordinary shares." As a result, prior to the Initial Public Offering,&#13;the Company's initial shareholders held 2,875,000 founder shares. The 2,875,000 founder shares included an aggregate of up&#13;to 375,000 ordinary shares subject to forfeiture to the extent that the over-allotment option was not exercised by the underwriters&#13;in full or in part. On November 20, 2018, as a result of the underwriters' partial exercise of their over-allotment option,&#13;3,002 founder shares were forfeited.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The founder shares are identical to the&#13;ordinary shares included in the units sold in the Initial Public Offering. However, the Initial Shareholders have agreed to (A)&#13;to vote any shares owned by them in favor of any proposed Business Combination, (B) not to convert any shares in connection with&#13;a shareholder vote to approve a proposed initial Business Combination or any amendment to the Company's charter documents&#13;prior to consummation of an initial Business Combination, or sell any shares to the Company in a tender offer in connection with&#13;a proposed initial Business Combination and (C) that the founder shares shall not participate in any liquidating distribution from&#13;the Trust Account upon winding up if a Business Combination is not consummated.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Additionally, subject to certain limited&#13;exceptions, the Initial Shareholders have agreed not to transfer, assign or sell any of the founder shares (except to certain permitted&#13;transferees) until, with respect to 50% of the founder shares, the earlier of (i) six months after the date of the consummation&#13;of a Business Combination, or (ii) the date on which the closing price of the Company's ordinary shares equals or exceeds&#13;$12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days&#13;within any 30-trading day period commencing after a Business Combination, and with respect to the remaining 50% of the founder&#13;shares, upon six months after the date of the consummation of a Business Combination, or earlier, in each case, if, subsequent&#13;to a Business Combination, the Company consummates a subsequent liquidation, merger, stock exchange or other similar transaction&#13;which results in all of the Company's shareholders having the right to exchange their ordinary shares for cash, securities&#13;or other property.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Related Party Advances&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In the Company's formation process,&#13;the Sponsor advanced HK$22,000, equivalent to US$2,818, to pay for the legal expenses associated with the business registration.&#13;On September 5, 2018, the Sponsor advanced the Company an additional HK$1,985 (equivalent to US$256) for bank service charges.&#13;The Company repaid the Sponsor $2,818 and $256 on July 6, 2018 and December 28, 2018, respectively. On October 19, 2018, the Company's&#13;Sponsor advanced the Company an additional $71,000 for costs associated with the Initial Public Offering. Such advances were non-interest&#13;bearing and were repaid by the Company on November 15, 2018.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;To participate in the private placement&#13;in connection with the Initial Public Offering, the Company's Sponsor made a deposit of $3,299,979 (net&#13;of a bank service charge) into the Company's escrow account on October 21, 2018. Because the Company's underwriter&#13;did not exercise its over-allotment option in full and cancelled the remaining portion on November 20, 2018, the Company's&#13;Sponsor subscribed to a total of 329,760 Private Units for $3,297,600, and the remaining $2,379 was repaid by the Company to the&#13;Sponsor as of March 31, 2019.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Related Party Loan &amp;#8211; Promissory Note&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;On July 6, 2018, the Sponsor loaned the&#13;Company $300,000 under a promissory note, a portion of which was used to pay for costs associated with the Initial Public Offering.&#13;The loan is non-interest bearing, unsecured and due at the closing of a Business Combination.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Related Party Loans&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In addition, in order to finance transaction&#13;costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company's&#13;officers and directors may, but are not obligated to, loan the Company funds as may be required ("Working Capital Loans").&#13;If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust&#13;Account released to the Company. The Working Capital Loans would either be repaid upon consummation of a Business Combination,&#13;without interest, or, at the lender's discretion, up to $1,500,000 of such Working Capital Loans may be converted into&amp;#160;units&#13;of the post Business Combination entity at a price of&amp;#8201;$10.00 per unit. The&amp;#160;units would be identical to the Private&#13;Units. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust&#13;Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital&#13;Loans.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;Administrative Service Fee&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company has agreed, commencing on August&#13;1, 2018, to pay the Sponsor, a monthly fee of an aggregate of $1,000 for general and administrative services including office space,&#13;utilities and secretarial support, due before the first day of each month. This arrangement will terminate upon the completion&#13;of a Business Combination or a distribution of the Trust Account to the public shareholders. For the three months ended March 31,&#13;2019, the Company incurred administrative fees of $3,000.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-01-0" xlink:label="Foot-01_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-01_loc" xlink:to="Footnote-03" order="1" />
      <link:loc xlink:type="locator" xlink:href="#Foot-02-0" xlink:label="Foot-02_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-02_loc" xlink:to="Footnote-02" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Income attributable to ordinary shares subject to possible redemption was calculated in portion of the interest income earned in Trust Account, which would be distributed to shareholders in the event they choose to exercise their redemption rights at the closing of a Business Combination.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-02" xml:lang="en-US">Excludes an aggregate of up to 10,593,284 shares subject to possible redemption at March 31, 2019.</link:footnote>
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-03" xml:lang="en-US">Excludes an aggregate of up to 10,593,284 ordinary shares subject to possible redemption at March 31, 2019.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
